These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3886710)

  • 1. The uricosuric effect of oxaprozin in humans.
    Goldfarb S; Walker BR; Agus ZS
    J Clin Pharmacol; 1985 Mar; 25(2):144-8. PubMed ID: 3886710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney.
    Mitnick PD; Greenberg A; DeOreo PB; Weiner BM; Coffman TM; Walker BR; Agus ZS; Goldfarb S
    Clin Pharmacol Ther; 1980 Nov; 28(5):680-9. PubMed ID: 7002426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaprozin pharmacokinetics in the elderly.
    Greenblatt DJ; Matlis R; Scavone JM; Blyden GT; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1985 Mar; 19(3):373-8. PubMed ID: 3986088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and kinetics of oxaprozin in normal subjects.
    Janssen FW; Jusko WJ; Chiang ST; Kirkman SK; Southgate PJ; Coleman AJ; Ruelius HW
    Clin Pharmacol Ther; 1980 Mar; 27(3):352-62. PubMed ID: 7357792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of food on oxaprozin bioavailability.
    Chiang ST; Knowles JA; Hubsher JA; Ruelius HW; Walker BR
    J Clin Pharmacol; 1984; 24(8-9):381-5. PubMed ID: 6480879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaprozin disposition in renal disease.
    Chiang ST; Morrison G; Knowles JA; Ruelius HW; Walker BR
    Clin Pharmacol Ther; 1982 Apr; 31(4):509-15. PubMed ID: 7060332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
    Goto J; Muramatsu M; Hosoda K; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-inflammatory activity of a non-steroidal anti-inflammatory agent, oxaprozin, in experimental models].
    Higuchi S; Osada Y; Shioiri Y; Nakaike S; Muramatsu M; Tanaka M; Arai I; Amanuma F; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):383-94. PubMed ID: 6432656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of oxaprozin with acetaminophen, cimetidine, and ranitidine.
    Scavone JM; Greenblatt DJ; Matlis R; Harmatz JS
    Eur J Clin Pharmacol; 1986; 31(3):371-4. PubMed ID: 3792438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroscopic evaluation of the effect of aspirin and oxaprozin on the gastric mucosa.
    Lanza FL; Hubsher JA; Walker BR
    J Clin Pharmacol; 1981 Apr; 21(4):157-61. PubMed ID: 7240437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaprozin pharmacokinetics in patients with congestive heart failure.
    Ochs HR; Greenblatt DJ; Knüchel M
    Arzneimittelforschung; 1986 Dec; 36(12):1837-40. PubMed ID: 3566846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric irritation of oxaprozin, a new nonsteroidal, antiinflammatory drug, in comparison to acetylsalicylic acid and indomethacin: a gastric potential difference analysis.
    Lücker PW; Venitz J; Ahrens S; Kaiser PM
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):469-75. PubMed ID: 3683021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxaprozin alone or in combination with aspirin on hemostasis and plasma protein binding.
    Kahn SB; Hubsher JA
    J Clin Pharmacol; 1983 Apr; 23(4):139-46. PubMed ID: 6863578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The analgesic and antipyretic effects of a non-steroidal anti-inflammatory drug, oxaprozin, in experimental animals].
    Amanuma F; Okuyama S; Orikasa S; Hashimoto S; Yamada C; Sakagawa T; Tsutsui Y; Tarumoto Y; Aihara H; Kameyama T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):345-54. PubMed ID: 6611288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre double-blind comparison of oxaprozin aspirin therapy on rheumatoid arthritis.
    Hubsher JA; Ballard IM; Walker BR; Gold JA
    J Int Med Res; 1979; 7(1):69-76. PubMed ID: 369925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Brogden RN
    Drugs; 1986 Oct; 32(4):291-312. PubMed ID: 3536423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A drug-drug interaction study of a novel, selective urate reabsorption inhibitor dotinurad and the non-steroidal anti-inflammatory drug oxaprozin in healthy adult males.
    Furihata K; Nagasawa K; Hagino A; Kumagai Y
    Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):36-43. PubMed ID: 32076889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone increases glomerular filtration rate, urinary kallikrein excretion and uric acid clearance in normal women.
    Atallah AN; Guimarães JA; Gebara M; Sustovich DR; Martinez TR; Camano L
    Braz J Med Biol Res; 1988; 21(1):71-4. PubMed ID: 3179582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects.
    Don BR
    Clin Nephrol; 2001 Jan; 55(1):45-52. PubMed ID: 11200867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.